dimebon.pngNo, I don’t actually think it can. The old bitch is pretty far gone. But it can help people that may be falling into the crazies at their earlier stages. Dimebon, (димебон) if you haven’t been under a rock, is a drug used to treat allergies1 in Russia. A startup in San Fran has discovered and announced that this simple indole compound can treat Alzheimer’s with a significant advantage over placebos. As I understand, it has been around for over 20 years, thus the patent is well expired. It’s thus bizarre that the company promoting the drug – Medivation, should be having such terrific luck with their stock. Of course, they’ve filed a huge patent for the specific treatment of Alheimer’s as well as multiple derivations (i.e. the functionality of R, R’ and R” are protected, though I’m not sure if it isn’t also a part of the ‘formulation’ business which, as I’ll get to, is going to make thing billionaires.) What’s going to keep this drug from getting all over America and ruining Medivation? It’s small, dirt cheap and the structure has no patent. The answer is, of course, because it’s not approved for use in the US, which means it will be prescription only here. Since the Americans rightfully pay the lion’s share to the drug companies that uncover these things, that’ll be just fine for them. I say Medivation is a STRONG BUY.

I personally congratulate Medivation for their work. While the compound certainly isn’t novel, the gusto and foresight to undergo phase II clinical trials on something that could revolutionize the way neurodegenerative diseases are treated is well worth it. Of course, Russians take no issue with dumping and shipping drugs into the US despite American demands that they don’t do it. It’s just their way of loving us…

1It’s both an antihistamine and a sleeping aid. So, they’ll be horribly druged up, which may net in zero returns in terms of how accessible the patient is mentally… Which may explain the dropout rate of over 30%. Then again, these people DO have Alzheimer’s, which may also explain it.